puls delay rest
guidanc involv sever differ driver
break new ground continu expect upsid spine
margin puls delay clear disappoint
like impact robot time financi impact
quarter in-lin pre-announc report revenu
vs mse organ impli bp momentum
deceler consist pre-announc us spine grew
bp momentum deceler in-lin estim driven
continu penetr msd growth cervic us surgic support
growth organ beat estim bp driven biolog return
growth vs mse growth organ beat
estim bp acceler bp momentum basi europ
standout region intern grow continu take
share select ou region margin bp y/i line
estim driven manufactur effici disciplin spend
partial off-set increas stock-bas comp headwind discuss
ep beat estim mainli driven tax vs mse
puls timelin push puls nuvas integr ecosystem spine
procedur workflow began beta test prior
earn call manag commentari point toward full
commerci modest revenu contribut begin howev
manag state base feedback receiv beta test compani
plan make addit iter system relat valid
verif ahead full-scal launch effect push launch
timelin revenu contribut month clear neg
sentiment perspect believ contribut embed
number nomin bp growth question
becom robot timelin push well manag state
develop work parallel therefor first-in-human still
track possibl see bull-cas scenario would
surpris compani move first human commerci
month therefor expect robot launch discuss
dont see factor us spine growth could
prove overhang investor consid
medic technolog unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
dissect compon guidanc guid cc growth
modestli light preview estim face
valu concern given ceo chri barri recent histori set
achiev target deliv upsid context cc growth guidanc
initi cc deliv net model
top end cc growth guidanc organ remain comfort
outlin key detail segment guidanc
us spine cc growth guidanc in-lin expect
us spine growth strongest year sinc
driven new product slightli improv market see
anoth strong year us spine growth similar driver
commentari suggest ampl runway surgeon convers
expect new product cervic deform also tailwind
growth fill key portfolio gap model us spine growth
like prove conserv see reason expect
deceler compani deliv anoth year would
add increment bp corpor
us surgic support segment guidanc light
estim see primari driver lighter guid challeng
comp impact bill normal puls contribut
push discuss although latter believ
materi contribut origin forecast net model
midpoint guidanc remain comfort
cc growth guidanc modestli
model see conserv given comp eas growth
lightest perform year nuvas continu
expand key region outsid us europ demonstr
recent sign strength model organ growth intern
may prove conserv note point intern upsid
drive bp corpor
margin upsid expect oper margin guidanc impli flat
margin low end bp top end consist expect
recent manag commentari ep guidanc initi
y/i bracket street commentari allud heighten
invest certain area steril packag mdr puls etc
may weigh margin expect gross margin stabl suppli chain
headwind off-set manufactur effici see major
leverag come sg although margin like pressur sbc
headwind term magnitud top-line and/or upsid deliv
point margin achiev like manag reinvest
sustain top-line growth support therefor see bp margin
reason target similar top-line perform
nuvas initi margin guidanc deliv
expect similar result moreso referenc model
margin bp y/i like prove conserv note
increment bp margin drive bp ep
solid finish puls speed bump state outlook
nuvas invest case progress look attract driven
new leadership consist execut competit robot offer
realist above-consensu lrp target see continu market
growth spine driven new product launch remain
key valu driver puls launch puls delay modest
headwind sentiment perspect financi impact minim
therefor concern compani deliv upsid
margin thesi remain unchang continu see modest margin
expans execut remain key price target base
ebitda discount smid cap peer
investor day set forth
achiev target sever
pocket conservat particularli us
spine pulse/robot
real sever driver lead
point margin expans
compani deliv consist
upsid guidanc consensu estim
lead recoveri multipl
view descript risk reward theme
deriv base case scenario price target base ebitda
estim discount smid cap peer see warrant given exposur
challeng end-market modestli off-set compani demonstr
abil acceler growth expand margin
us spine growth maintain high
singl digit intern grow high-
teen puls eventu robot
placement ramp faster anticip
lead long-term pull-through
manufactur improv
efcienc drive bp margin
growth prole driven share gain us
spine intern penetr puls
robot drive upsid uss revenu
gener implant pull-through longer-
term compani abl expand
margin bp per year drive dd
spine market remain pressur
gap vs peer margin progress
mute compani continu struggl
manufactur improv
point us spine growth worth bp
puls system placement drive
bp growth
point margin expans drive point
china india
view explan region hierarchi
research highest favor quintil
spine growth acceler hsd driven
robot platform launch earlier
robot gap lengthen lose
price pressur ampli core spine
margin target overli ambiti
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
million except ep
sale
sale
sale
sale
sale
sale
net loss attribut non-controlling interest
good sold
equival
prepaid expens current asset
properti equip net
restrict invest
account payabl accru liabil
accru payrol liabil
depreci amort
amort non-cash interest
impair intang asset
allow doubt account sale return reserves-
allow excess obsolet inventori net write-off
accret conting consider
chang oper asset liabil net effect acquisit
prepaid expens asset
account payabl accru liabil
accru payrol relat expens liabil
paid busi asset acquisit
purchas properti equip
purchas market secur
sale market secur
purchases/sal restrict invest
invest activ
payment note
tax benefit relat stock-bas compens awards-
proce issuanc common stock
purchas treasuri stock
financ activ
effect exchang rate chang
begin period
end period
